Coupang is reportedly looking to achieve a $50bn market cap following a planned listing that would offer an exit to both SoftBank and its Vision Fund.

NexImmune priced shares at $17 to raise $110m in an upsized offering, enabling Amgen and Pfizer to exit the Johns Hopkins University spinout.

IWG has acquired a majority stake in the co-working space provider just weeks after GV bought the shares held by WeWork.

The Petco-backed pet services provider is set to be valued at about $1.6bn in a deal that will involve it listing on the Nasdaq Capital Market.

The past week's M&A exits included Genetirate, DataFleets and SightGlass Vision.

The medical documentation tool developer has been acquired by Nuance Communications having raised $7.5m from investors including NewYork-Presbyterian.

Bloomberg Beta and GV are set to exit the data analytics technology developer in a $155m transaction that will follow about $33m in funding.

Adways, Fidelity, Nissay Capital, Opt, SMBC Venture Capital and Voyage Ventures are all set to exit the C2C skills marketplace operator in an offering on TSE’s Mothers Market.

The CBRE, Ericsson, AMD, News Corp, PTC and Qualcomm-backed spatial modelling technology provider will list on the Nasdaq Capital Market through the deal.

Total is set to score an exit from the fuel cell vehicle developer just four months on from its investment, through a reverse merger that will value Hyzon at $2.1bn once the deal closes.